HMNI’s Gyroscopic Radiosurgery® For The Brain To Shorten Time From Diagnosis To Treatment

The Dr. Robert H. and Mary Ellen Harris ZAP-X Center for Noninvasive Neurosurgery, situated within the Hackensack Meridian Neuroscience Institute of Jersey Shore University Medical Center, is on the brink of introducing a groundbreaking advancement in medical technology. 

The center is poised to unveil the world’s inaugural ZAP-X® Gyroscopic Radiosurgery®, in conjunction with Synaptive’s noiseless brain MRI, specifically designed for treating brain tumors and various brain-related ailments, including trigeminal neuralgia and arteriovenous malformations (AVM). Marking a significant milestone, this academic medical institution will pioneer the utilization of ZAP-X, become the first hospital in the Northeastern United States to provide Synaptive’s head-only MRI, and hold the distinction of being the sole global facility to combine these innovative technologies. The integration of these two cutting-edge technologies promises to substantially reduce the time between diagnosis and treatment.

Robert C. Garrett, FACHE, the CEO of Hackensack Meridian Health, emphasized the organization’s commitment to enhancing patient care through the adoption of advanced technologies, stating, “Having the latest advancements in technology to treat our patients is part of how Hackensack Meridian Health keeps getting better.” He further acknowledged the significance of the introduction of ZAP-X Gyroscopic Radiosurgery and Synaptive MRI, not only in providing superior care to the communities within New Jersey but also in solidifying the network’s reputation as a leading healthcare provider.

The innovative technology is set to become operational at Jersey Shore University Medical Center in Neptune, NJ, with the generous support of Mary Ellen Harris and the Golden Dome Foundation. Shabbar Danish, M.D., the chair of neurosurgery at the Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center, expressed excitement about bringing this advanced form of cranial radiosurgery to patients. Dr. Danish highlighted ZAP-X’s potential as a powerful tool in non-invasively treating brain tumors and other cranial conditions. He envisioned a future where this technology becomes an industry standard, significantly benefiting patients through effective, non-invasive, and timely treatment options.

ZAP-X represents just one of the many state-of-the-art tools available at Hackensack Meridian Health for combating both benign and metastatic tumors. While ZAP-X is tailored specifically for brain-related conditions, the network is adept at employing similar radiosurgery techniques, including CyberKnife, Gamma Knife, and proton therapy. Additionally, the Hackensack Meridian John Theurer Cancer Center (JTCC) is gearing up to introduce Scintix™ by Reflexion, an innovative therapy for patients primarily afflicted with metastatic cancer. 

This groundbreaking technology harnesses continuously updated data throughout treatment sessions to precisely deliver radiotherapy. This will be combined with precision medicine or customized treatments, offering new options for patients that were previously unavailable. JTCC is one of only seven institutions worldwide to adopt this technology and is poised to revolutionize radiation oncology in New Jersey.

The ZAP-X and Synaptive MRI equipment is currently being installed at the Dr. Robert H. and Mary Ellen Harris ZAP-X Center for Noninvasive Neurosurgery at Jersey Shore University Medical Center. The Neuroscience Institute is gearing up to commence patient treatments with this groundbreaking technology in the upcoming fall season.

For individuals seeking more information about ZAP-X and Synaptive MRI, as well as other available treatments, comprehensive details are available on the institution’s official website.

As for the Hackensack Meridian Neuroscience Institute, it stands as the preeminent and most comprehensive Neuroscience Institute in New Jersey. Encompassing neurology and neurosurgery programs across three academic medical centers—Hackensack University Medical Center, Jersey Shore University Medical Center, and JFK University Medical Center—the Neuroscience Institute’s prominence extends nationwide. 

The Institute has earned various accolades, including Hackensack University Medical Center (HUMC) being ranked #22 for neurology and neurosurgery by US News and World Report. All Neuroscience Institute centers have secured the prestigious Comprehensive Stroke Center designation from the Joint Commission. The Institute boasts specialized Centers of Excellence in ALS, Multiple Sclerosis, Stroke, and Cranial Surgery. The Institute has garnered additional recognitions for excellence from Healthgrades, the Joint Commission, and the American Heart Association/American Stroke Association. 

The Institute stands at the forefront of neurological technology with advanced features like High Intensity Focused Ultrasound, Quicktome brain mapping, and Surgical Theater augmented reality for brain surgery—exclusive offerings within New Jersey. Soon, the Neuroscience Institute will take another stride by offering Zap-X Radiosurgery with Synaptive MRI, enabling non-invasive treatment for brain tumors and other brain conditions within as little as a week from diagnosis, an unparalleled accomplishment on the global stage.